Update on the pharmacogenomics of proton pump inhibitors

Hip Fracture and Proton Pump Inhibitor Therapy: Position Statement

(2016) Paul Moayyedi   CANADIAN JOURNAL OF GASTROENTEROLOGY

Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping

(2010) S. Miehlke et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype

(2010) Nuala A. Helsby et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drug-Drug Interaction Profiles of Proton Pump Inhibitors

(2010) Ryuichi Ogawa et al.   CLINICAL PHARMACOKINETICS

Helicobacter pylorieradication therapy

(2010) Hidekazu Suzuki et al.   Future Microbiology

Safety of Proton Pump Inhibitor Exposure

(2010) Yu–Xiao Yang et al.   GASTROENTEROLOGY

The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole

(2010) Jeong Hoon Lee et al.   Gut and Liver

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2010) Neena S. Abraham et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pharmacogenomics: Bridging the gap between science and practice

(2010) Kelly C. Lee et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Interaction of Clopidogrel and Omeprazole

(2010) Mary Ross Southworth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clopidogrel with or without Omeprazole in Coronary Artery Disease

(2010) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of the long-term use of proton pump inhibitors

(2010) Alan BR Thomson   WORLD JOURNAL OF GASTROENTEROLOGY

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

(2009) N. G. HUNFELD et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

AJG Series: Molecular Biology for Clinicians

(2009) Yuri A Saito et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?

(2009) Loren Laine et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

(2009) Alain Li-Wan-Po et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Current Standings of the Proton Pump Inhibitor and Clopidogrel Co-Therapy: Review on an Evolving Field with the Eyes of the Gastroenterologist

(2009) Márk Juhász et al.   DIGESTION

Proton pump inhibitors: actions and reactions

(2009) James M. Mullin et al.   DRUG DISCOVERY TODAY

Impact of Intestinal CYP2C19 Genotypes on the Interaction between Tacrolimus and Omeprazole, but Not Lansoprazole, in Adult Living-Donor Liver Transplant Patients

(2009) K. Hosohata et al.   DRUG METABOLISM AND DISPOSITION

CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole

(2009) Takahisa Furuta et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Influence of inflammatory cytokine polymorphisms on eradication rates ofHelicobacter pylori

(2009) Mitsushige Sugimoto et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Influence of Lansoprazole and Rabeprazole on Mycophenolic Acid Pharmacokinetics One Year After Renal Transplantation

(2009) Masatomo Miura et al.   THERAPEUTIC DRUG MONITORING

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

(2008) Ulrich M. Zanger et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor-Based Triple Therapy forHelicobacter pyloriEradication: A Meta-Analysis

(2008) Fujun Zhao et al.   HELICOBACTER

Effect of the CYP2C19 polymorphism on the eradication rate ofHelicobacter pyloriinfection by 7-day triple therapy with regular proton pump inhibitor dosage

(2008) Jung Mook Kang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effects of CYP2C19 and MDR1 genotype on the eradication rate ofHelicobacter pyloriinfection by triple therapy with pantoprazole, amoxycillin and clarithromycin

(2008) Jung-Hwan Oh et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Proton pump inhibitors in GORDAn overview of their pharmacology, efficacy and safety

(2008) Vincenzo Savarino et al.   PHARMACOLOGICAL RESEARCH

Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation

(2007) Hiro-o Yamano et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY